Details for New Drug Application (NDA): 017687
✉ Email this page to a colleague
NDA 017687 describes XENON XE 133-V.S.S., which is a drug marketed by Ge Healthcare and is included in one NDA. Additional details are available on the XENON XE 133-V.S.S. profile page.
The generic ingredient in XENON XE 133-V.S.S. is xenon xe-133. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.
The generic ingredient in XENON XE 133-V.S.S. is xenon xe-133. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.
Summary for 017687
| Tradename: | XENON XE 133-V.S.S. |
| Applicant: | Ge Healthcare |
| Ingredient: | xenon xe-133 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | GAS;INHALATION | Strength | 10mCi/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | GAS;INHALATION | Strength | 10mCi/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | GAS;INHALATION | Strength | 20mCi/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
